BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17409394)

  • 1. Dual role of inactivating Lef1 mutations in epidermis: tumor promotion and specification of tumor type.
    Niemann C; Owens DM; Schettina P; Watt FM
    Cancer Res; 2007 Apr; 67(7):2916-21. PubMed ID: 17409394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.
    Honeycutt KA; Chen Z; Koster MI; Miers M; Nuchtern J; Hicks J; Roop DR; Shohet JM
    Oncogene; 2006 Jul; 25(29):4027-32. PubMed ID: 16518415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.
    Russell JL; Weaks RL; Berton TR; Johnson DG
    Oncogene; 2006 Feb; 25(6):867-76. PubMed ID: 16205640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis.
    Wang XJ; Greenhalgh DA; Jiang A; He D; Zhong L; Medina D; Brinkley BR; Roop DR
    Oncogene; 1998 Jul; 17(1):35-45. PubMed ID: 9671312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic deletion of p21WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis.
    Weinberg WC; Fernandez-Salas E; Morgan DL; Shalizi A; Mirosh E; Stanulis E; Deng C; Hennings H; Yuspa SH
    Cancer Res; 1999 May; 59(9):2050-4. PubMed ID: 10232585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in IkappaB kinase alpha expression promotes the development of skin papillomas and carcinomas.
    Park E; Zhu F; Liu B; Xia X; Shen J; Bustos T; Fischer SM; Hu Y
    Cancer Res; 2007 Oct; 67(19):9158-68. PubMed ID: 17909021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
    Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
    Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of invasive mouse skin carcinomas in transgenic mice with mutations in both H-ras and p53.
    Zhang Z; Yao R; Li J; Wang Y; Boone CW; Lubet RA; You M
    Mol Cancer Res; 2005 Oct; 3(10):563-74. PubMed ID: 16254190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cyclooxygenase-2 overexpression on skin carcinogenesis is context dependent.
    Rundhaug JE; Pavone A; Kim E; Fischer SM
    Mol Carcinog; 2007 Dec; 46(12):981-92. PubMed ID: 17583568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human sebaceous tumors harbor inactivating mutations in LEF1.
    Takeda H; Lyle S; Lazar AJ; Zouboulis CC; Smyth I; Watt FM
    Nat Med; 2006 Apr; 12(4):395-7. PubMed ID: 16565724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development.
    Bai Y; Edamatsu H; Maeda S; Saito H; Suzuki N; Satoh T; Kataoka T
    Cancer Res; 2004 Dec; 64(24):8808-10. PubMed ID: 15604236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin epidermis lacking the c-Myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene.
    Oskarsson T; Essers MA; Dubois N; Offner S; Dubey C; Roger C; Metzger D; Chambon P; Hummler E; Beard P; Trumpp A
    Genes Dev; 2006 Aug; 20(15):2024-9. PubMed ID: 16882980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation of Ha-ras and Bcl-2 during multistep skin carcinogenesis.
    Lee S; Chari NS; Kim HW; Wang X; Roop DR; Cho SH; DiGiovanni J; McDonnell TJ
    Mol Carcinog; 2007 Dec; 46(12):949-57. PubMed ID: 17538944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha 2-HS glycoprotein (fetuin-A) modulates murine skin tumorigenesis.
    Leite-Browning ML; McCawley LJ; Jahnen-Dechent W; King LE; Matrisian LM; Ochieng J
    Int J Oncol; 2004 Aug; 25(2):319-24. PubMed ID: 15254728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of c-myc on stem cell fate influences skin tumor phenotype.
    Honeycutt KA; Waikel RL; Koster MI; Wang XJ; Roop DR
    Mol Carcinog; 2010 Apr; 49(4):315-9. PubMed ID: 20146250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of nevi and skin tumors in Ink4a/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures.
    van Schanke A; van Venrooij GM; Jongsma MJ; Banus HA; Mullenders LH; van Kranen HJ; de Gruijl FR
    Cancer Res; 2006 Mar; 66(5):2608-15. PubMed ID: 16510579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8.
    Schaper ID; Marcuzzi GP; Weissenborn SJ; Kasper HU; Dries V; Smyth N; Fuchs P; Pfister H
    Cancer Res; 2005 Feb; 65(4):1394-400. PubMed ID: 15735026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haploinsufficiency for odc modifies mouse skin tumor susceptibility.
    Guo Y; Cleveland JL; O'Brien TG
    Cancer Res; 2005 Feb; 65(4):1146-9. PubMed ID: 15734996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-stage (initiation-promotion) carcinogenesis in vivo and in vitro.
    Chouroulinkov I; Lasne C
    Bull Cancer; 1978; 65(3):255-64. PubMed ID: 102382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis.
    Ruddell A; Kelly-Spratt KS; Furuya M; Parghi SS; Kemp CJ
    Oncogene; 2008 May; 27(22):3145-55. PubMed ID: 18059331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.